Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.

Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2354-63. doi: 10.1158/1055-9965.EPI-13-0668. Epub 2013 Oct 15.

2.

Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.

Russnes KM, Wilson KM, Epstein MM, Kasperzyk JL, Stampfer MJ, Kenfield SA, Smeland S, Blomhoff R, Giovannucci EL, Willett WC, Mucci LA.

Int J Cancer. 2014 Mar 1;134(5):1156-65. doi: 10.1002/ijc.28438. Epub 2013 Nov 11.

3.

Consumption of fish products across the lifespan and prostate cancer risk.

Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L.

PLoS One. 2013 Apr 17;8(4):e59799. doi: 10.1371/journal.pone.0059799. Print 2013.

4.

A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA.

Clin Cancer Res. 2013 Mar 15;19(6):1612-9. doi: 10.1158/1078-0432.CCR-12-2718. Epub 2013 Feb 4.

5.

Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.

Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci E, Price A, Wolk A, Håkansson N, Fall K, Andersson SO, Andrén O.

Am J Epidemiol. 2012 Aug 1;176(3):240-52. doi: 10.1093/aje/kwr520. Epub 2012 Jul 10.

6.

Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.

Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA.

Cancer Causes Control. 2012 Aug;23(8):1359-66. doi: 10.1007/s10552-012-0016-9. Epub 2012 Jun 19.

7.

Rye bread consumption in early life and reduced risk of advanced prostate cancer.

Torfadottir JE, Valdimarsdottir UA, Mucci L, Stampfer M, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Adami HO, Gudnason V, Steingrimsdottir L.

Cancer Causes Control. 2012 Jun;23(6):941-50. doi: 10.1007/s10552-012-9965-2. Epub 2012 Apr 25.

8.

Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.

Pettersson A, Kasperzyk JL, Kenfield SA, Richman EL, Chan JM, Willett WC, Stampfer MJ, Mucci LA, Giovannucci EL.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):428-36. doi: 10.1158/1055-9965.EPI-11-1004. Epub 2012 Feb 7.

9.

Milk intake in early life and risk of advanced prostate cancer.

Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA.

Am J Epidemiol. 2012 Jan 15;175(2):144-53. doi: 10.1093/aje/kwr289. Epub 2011 Dec 20.

10.

Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.

Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, Stampfer MJ, Mucci LA.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):28-32. doi: 10.1016/j.ijrobp.2011.05.032. Epub 2011 Nov 11.

11.

Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.

Kasperzyk JL, Shappley WV 3rd, Kenfield SA, Mucci LA, Kurth T, Ma J, Stampfer MJ, Sanda MG.

J Urol. 2011 Nov;186(5):1862-7. doi: 10.1016/j.juro.2011.06.058. Epub 2011 Sep 23.

12.

Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study.

Kasperzyk JL, Chang ET, Birmann BM, Kraft P, Zheng T, Mueller NE.

Am J Epidemiol. 2011 Oct 1;174(7):816-27. doi: 10.1093/aje/kwr190. Epub 2011 Aug 1.

13.

Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.

Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA.

J Natl Cancer Inst. 2011 Jun 8;103(11):876-84. doi: 10.1093/jnci/djr151. Epub 2011 May 17.

14.

Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E.

J Clin Oncol. 2011 Jun 10;29(17):2378-85. doi: 10.1200/JCO.2010.30.9880. Epub 2011 May 2.

15.

Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.

Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E.

PLoS One. 2011 Apr 6;6(4):e18625. doi: 10.1371/journal.pone.0018625.

16.

Dietary zinc and prostate cancer survival in a Swedish cohort.

Epstein MM, Kasperzyk JL, Andrén O, Giovannucci EL, Wolk A, Håkansson N, Andersson SO, Johansson JE, Fall K, Mucci LA.

Am J Clin Nutr. 2011 Mar;93(3):586-93. doi: 10.3945/ajcn.110.004804. Epub 2011 Jan 12.

17.

Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort.

Shappley WV 3rd, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan JM.

J Clin Oncol. 2009 Oct 20;27(30):4980-5. doi: 10.1200/JCO.2008.21.2613. Epub 2009 Aug 31.

18.

One-carbon metabolism-related nutrients and prostate cancer survival.

Kasperzyk JL, Fall K, Mucci LA, Håkansson N, Wolk A, Johansson JE, Andersson SO, Andrén O.

Am J Clin Nutr. 2009 Sep;90(3):561-9. doi: 10.3945/ajcn.2009.27645. Epub 2009 Jul 1.

19.

Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.

Chang ET, Birmann BM, Kasperzyk JL, Conti DV, Kraft P, Ambinder RF, Zheng T, Mueller NE.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):976-86. doi: 10.1158/1055-9965.EPI-08-1130. Epub 2009 Feb 17.

20.

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.

Baek RC, Kasperzyk JL, Platt FM, Seyfried TN.

Neurochem Int. 2008 May;52(6):1125-33. doi: 10.1016/j.neuint.2007.12.001. Epub 2007 Dec 8.

PMID:
18207611

Supplemental Content

Loading ...
Support Center